Sectors
BEAM
Beam Therapeutics Inc.
29.31
1 x 25.80
3 x 36.64
bid
ask
-
0.01
0.05%
02:09 PM
timesize
| Ytd | 5.72% | |
| 1y | 79.13% |
28.33
day range
29.47
16.02
52 week range
38.26
| Open | 28.82 | Prev Close | 29.32 | Low | 28.33 | High | 29.47 | Mkt Cap | 3.03B |
| Vol | 533.90K | Avg Vol | 2.14M | EPS | -0.69 | P/E | N/A | Forward P/E | -6.18 |
| Beta | 2.23 | Short Ratio | 13.28 | Inst. Own | 107.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 29.83 | 200-d Avg | 28.34 | 1yr Est | 52.15 |
| Income Statement | |||
| Total Revenue | 490.00K | ||
| Revenues (USD) | 490.00K | ||
| Gross Profit | 490.00K | ||
| Operating Expenses | 127.04M | ||
| Research and Development Expense | 95.10M | ||
| Selling, General and Administrative Expense | 31.95M | ||
| Operating Income | -126.55M | ||
| Net Income | -122.68M | ||
| Net Income Common Stock | -122.68M | ||
| Net Income Common Stock (USD) | -122.68M | ||
| Consolidated Income | -122.68M | ||
| Earnings per Basic Share | -1.18 | ||
| Earnings per Basic Share (USD) | -1.18 | ||
| Earnings per Diluted Share | -1.18 | ||
| Earning Before Interest & Taxes (EBIT) | -122.68M | ||
| Earning Before Interest & Taxes (USD) | -122.68M | ||
| Weighted Average Shares | 104.33M | ||
| Weighted Average Shares Diluted | 104.33M | ||
| Balance Sheet | |||
| Cash and Equivalents | 226.54M | ||
| Cash and Equivalents (USD) | 226.54M | ||
| Investments | 933.10M | ||
| Investments Current | 933.10M | ||
| Current Assets | 1.18B | ||
| Property, Plant & Equipment Net | 193.19M | ||
| Total Assets | 1.39B | ||
| Debt Current | 15.21M | ||
| Total Debt | 247.36M | ||
| Current Liabilities | 80.88M | ||
| Debt Non-Current | 232.15M | ||
| Total Liabilities | 318.91M | ||
| Accumulated Retained Earnings (Deficit) | -1.86B | ||
| Accumulated Other Comprehensive Income | -2.19M | ||
| Shareholders Equity | 1.07B | ||
| Shareholders Equity (USD) | 1.07B | ||
| Assets Non-Current | 207.76M | ||
| Total Debt (USD) | 247.36M | ||
| Liabilities Non-Current | 238.03M | ||
| Trade and Non-Trade Payables | 13.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.41M | ||
| Net Cash Flow from Financing | 7.52M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -68.45M | ||
| Capital Expenditure | -2.41M | ||
| Issuance (Purchase) of Equity Shares | 7.52M | ||
| Net Cash Flow from Investing | -9.87M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -7.46M | ||
| Net Cash Flow from Operations | -66.10M | ||
| Share Based Compensation | 19.28M | ||